In the United States, generic drug substances are named through review and recommendation of the United States Adopted Names (USAN) Council.
•
Generic drugs are labeled with the name of the manufacturer and the adopted name (nonproprietary name) of the drug.
Food and Drug Administration | Drug Enforcement Administration | drug | Food and Drug Administration (United States) | Illegal drug trade | cannabis (drug) | Recreational drug use | Shoppers Drug Mart | Psychoactive drug | National Institute on Drug Abuse | Drug rehabilitation | Drug Abuse Resistance Education | Cannabis (drug) | Pure Food and Drug Act | Drug withdrawal | drug lord | psychoactive drug | Pharmaceutical drug | pharmaceutical drug | Federal Food, Drug, and Cosmetic Act | Drug Wars: The Camarena Story | Drug | Antiviral drug | recreational drug use | National Drug Intelligence Center | National Council on Alcoholism and Drug Dependence | Mexican Drug War | Illegal drug trade in Colombia | illegal drug trade | Generic Model Organism Database |
The organization filed several suits targeting pharmaceutical companies whom they alleged to have blocked competition over generic drug production and a class action law suit against Bristol-Myers Squibb, a pharmaceutical manufacturer, for alleged damages the company inflicted by delaying competition for BuSpar, a brand name anti-anxiety drug.
The Court rejected a challenge by the generic drug manufacturers Novopharm and Apotex to declare Glaxo Wellcome's patent for AZT, an AIDS-fighting drug, invalid.
On June 10, 2008, Daiichi Sankyo agreed to take a majority (35%) stake in Indian generic drug maker Ranbaxy, with a deal valued at about $4.6 billion.